Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age. [electronic resource]

By: Contributor(s): Producer: 20040617Description: 1406-14 p. digitalISSN:
  • 0264-410X
Subject(s): Online resources: In: Vaccine vol. 22
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study

There are no comments on this title.

to post a comment.